Twist Bioscience Corporation (TWST) DCF Valuation

Twist Bioscience Corporation (TWST) DCF -Bewertung

US | Healthcare | Medical - Diagnostics & Research | NASDAQ
Twist Bioscience Corporation (TWST) DCF Valuation
  • Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • Professional Design: Trusted, Industry-Standard Templates
  • Pre-Built For Quick And Efficient Use
  • No Expertise Is Needed; Easy To Follow

Twist Bioscience Corporation (TWST) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Unser DCF-Rechner von Twist Bioscience Corporation (TWST) für Genauigkeit entwickelt, ermöglicht es Ihnen, die Bewertung der Twist Bioscience Corporation anhand realer Finanzdaten zu bewerten und gleichzeitig vollständige Flexibilität zu bieten, um alle wesentlichen Parameter für erweiterte Projektionen zu ändern.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020
AY2
2021
AY3
2022
AY4
2023
AY5
2024
FY1
2025
FY2
2026
FY3
2027
FY4
2028
FY5
2029
Revenue 90.1 132.3 203.6 245.1 313.0 429.4 589.1 808.3 1,109.0 1,521.5
Revenue Growth, % 0 46.87 53.83 20.41 27.69 37.2 37.2 37.2 37.2 37.2
EBITDA -132.1 -143.9 -191.6 -174.2 -176.7 -362.1 -496.8 -681.6 -935.1 -1,282.9
EBITDA, % -146.6 -108.75 -94.1 -71.05 -56.46 -84.32 -84.32 -84.32 -84.32 -84.32
Depreciation 6.7 12.0 36.6 29.3 31.4 48.5 66.5 91.3 125.3 171.8
Depreciation, % 7.41 9.06 18 11.96 10.04 11.29 11.29 11.29 11.29 11.29
EBIT -138.8 -155.9 -228.2 -203.5 -208.1 -386.0 -529.6 -726.7 -997.0 -1,367.9
EBIT, % -154.01 -117.81 -112.1 -83.01 -66.5 -89.9 -89.9 -89.9 -89.9 -89.9
Total Cash 290.0 477.9 505.0 336.4 276.4 419.4 575.4 789.4 1,083.0 1,485.9
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 26.4 28.5 40.3 44.1 34.9
Account Receivables, % 29.27 21.57 19.79 17.98 11.15
Inventories 12.3 31.8 39.3 32.1 24.1 66.8 91.6 125.7 172.5 236.6
Inventories, % 13.64 24.03 19.31 13.08 7.69 15.55 15.55 15.55 15.55 15.55
Accounts Payable 4.8 14.9 20.1 14.1 1.6 28.1 38.6 52.9 72.6 99.6
Accounts Payable, % 5.36 11.26 9.87 5.73 0.52081 6.55 6.55 6.55 6.55 6.55
Capital Expenditure -9.9 -27.1 -101.9 -27.8 -5.1 -81.1 -111.2 -152.6 -209.4 -287.2
Capital Expenditure, % -10.95 -20.45 -50.04 -11.33 -1.62 -18.88 -18.88 -18.88 -18.88 -18.88
Tax Rate, % -0.26902 -0.26902 -0.26902 -0.26902 -0.26902 -0.26902 -0.26902 -0.26902 -0.26902 -0.26902
EBITAT -139.1 -154.0 -217.8 -204.6 -208.7 -381.6 -523.5 -718.2 -985.4 -1,351.9
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -176.2 -180.6 -297.1 -205.6 -177.6 -481.1 -614.4 -843.0 -1,156.6 -1,586.8
WACC, % 12.51 12.51 12.5 12.51 12.51 12.51 12.51 12.51 12.51 12.51
PV UFCF
SUM PV UFCF -3,107.2
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -1,619
Terminal Value -15,405
Present Terminal Value -8,546
Enterprise Value -11,654
Net Debt -141
Equity Value -11,512
Diluted Shares Outstanding, MM 58
Equity Value Per Share -198.43

What You Will Get

  • Editable Forecast Inputs: Effortlessly modify assumptions (growth %, margins, WACC) to generate various scenarios.
  • Real-World Data: Twist Bioscience Corporation’s (TWST) financial data pre-filled to kickstart your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Customizable and Professional: A refined Excel model that adjusts to your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.

Key Features

  • 🔍 Real-Life TWST Financials: Pre-filled historical and projected data for Twist Bioscience Corporation (TWST).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Twist's intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Twist's valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • 1. Access the Template: Download and open the Excel file featuring Twist Bioscience Corporation’s preloaded data.
  • 2. Modify Assumptions: Adjust essential inputs such as growth rates, WACC, and capital expenditures.
  • 3. View Results Instantly: The DCF model automatically calculates intrinsic value and NPV for (TWST).
  • 4. Explore Scenarios: Analyze various forecasts to evaluate different valuation results.
  • 5. Present with Confidence: Share professional valuation insights to bolster your decision-making process.

Why Choose This Calculator for Twist Bioscience (TWST)?

  • All-in-One Solution: Combines DCF, WACC, and financial ratio analyses tailored for biotech investments.
  • Flexible Inputs: Modify the highlighted cells to explore different financial scenarios.
  • In-Depth Analysis: Automatically computes Twist Bioscience’s intrinsic value and Net Present Value.
  • Preloaded Information: Access historical and projected data for reliable analysis.
  • Expert Level: Perfect for financial professionals, investors, and biotech consultants.

Who Should Use Twist Bioscience Corporation (TWST)?

  • Biotech Investors: Leverage advanced tools to make informed investment choices in the biotech sector.
  • Research Scientists: Access high-quality DNA synthesis services for your innovative projects.
  • Pharmaceutical Consultants: Quickly tailor solutions for clients in drug development and genomics.
  • Biotechnology Enthusiasts: Enhance your knowledge of synthetic biology and its applications through real-world case studies.
  • Educators and Students: Utilize it as a hands-on resource in biotechnology and life sciences curricula.

What the Template Contains

  • Pre-Filled DCF Model: Twist Bioscience’s financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Twist Bioscience’s profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.